Mashup Score:8
HealioNovel agents targeting Lp(a), triglycerides spearhead ‘profound change in therapies’ - 1 day
Mashup Score:8
Twitter Feed: Cardiology Today
Mashup Score:6
HealioNLA to unveil new scientific statements, focus on ‘lower is better’ for LDL management - 2 days
Mashup Score:6
The National Lipid Association Scientific Sessions, a hybrid meeting held Sept. 24-26, 2021, will include four featured sessions, updates on NLA scientific statements and...
-
ICYMI: #NLASessions will be delivered virtually as well as in-person in Orlando and all streamed sessions will be made available on demand from approximately 1 week after the live sessions @nationallipid #NLA2021 @dan_soffer @PennMedicine #CardioTwitter https://t.co/nbNme2LtNp - view on twitter
Mashup Score:5
HealioNLA scientific statement navigates genetic testing for certain dyslipidemias - 13 hours
Mashup Score:5
Genetic testing can be useful for some patients with dyslipidemia, but many factors must be considered when selecting a test, according to a National...
-
ICYMI: “Our goal was to create a user-friendly resource for genetic testing for hereditary dyslipidemias, and to answer commonly asked questions,” @nationallipid #NLASessions #cardiotwitter @LipidJournal @braun_lynne https://t.co/DawTFENYh8 - view on twitter
Mashup Score:3
HealioFuture therapeutics may dramatically lower LDL - 10 hours
Mashup Score:3
LDL-lowering therapeutics have evolved since the introduction of bile acid sequestrants in 1973, and approaches in development may prove even more effective than those...
-
ICYMI: According to the presentation, “the future is bright for LDL reduction,” with inclisiran and CRISPR gene therapy for heterozygous FH currently in the pipeline @nationallipid #NLASessions #cardiotwitter @DartmouthHitch #CardioTwitter https://t.co/M4svZlSGem - view on twitter
Mashup Score:2
Healio16th Annual Cardiometabolic Health Congress nears commencement - 23 hours
Mashup Score:2
The Cardiometabolic Health Congress is gearing up for the 16th Annual CMHC | Pushing Boundaries in Cardiometabolic Health: Challenges and Controversies.The event will feature...
-
ICYMI: Taking place October 14 to 17, in National Harbor, Maryland, the 16th Annual CMHC will offer direct access to leading academic experts, clinical researchers, and more through a wide variety of interactive sessions. @CMHC_CME #CMHC2021 #CardioTwitter https://t.co/ocicK5uTu7 - view on twitter
Mashup Score:2
HealioHigh maximum BP after endovascular stroke therapy tied to hemorrhage risk, poor outcomes - 2 days
Mashup Score:2
High maximum systolic BP in the immediate hours following endovascular therapy for ischemic stroke is associated with poor functional outcome and increased risk for...
-
ICYMI: “Since BP is an important factor affecting cerebral perfusion, it is likely that BP within the first hours following EVT has an impact on infarct size and thereby functional outcome,” @StrokeAHA_ASA @healioneurology @erasmusuni #CardioTwitter https://t.co/te5TE6C3zL - view on twitter
More coverage:
#cardiotwitter
Mashup Score:2
HealioNLA scientific statement navigates genetic testing for certain dyslipidemias - 16 hours
Mashup Score:2
Genetic testing can be useful for some patients with dyslipidemia, but many factors must be considered when selecting a test, according to a National...
-
Genetic testing can be useful for some patients with dyslipidemia, but many factors must be considered when selecting a test, according to a @nationallipid scientific statement #NLASessions #cardiotwitter @LipidJournal @braun_lynne https://t.co/DawTFF5z8G - view on twitter
Mashup Score:2
Healio16th Annual Cardiometabolic Health Congress nears commencement - 1 day
Mashup Score:2
The Cardiometabolic Health Congress is gearing up for the 16th Annual CMHC | Pushing Boundaries in Cardiometabolic Health: Challenges and Controversies.The event will feature...
-
ICYMI: Taking place October 14 to 17, in National Harbor, Maryland, the 16th Annual CMHC will offer direct access to leading academic experts, clinical researchers, and more through a wide variety of interactive sessions. @CMHC_CME #CMHC2021 #CardioTwitter https://t.co/ocicK5diCz - view on twitter
Mashup Score:2
HealioNovel agents targeting Lp(a), triglycerides spearhead ‘profound change in therapies’ - 1 day
Mashup Score:2
Much research is being conducted on novel therapeutics to reduce residual lipid-related risks, a speaker said at the National Lipid Association Scientific Sessions.“It has...
-
ICYMI: “It turns out that, in addition to LDL particles, there are other atherogenic particles” that contribute to atherosclerosis, @CBallantyneMD said. @BCMFromtheLabs @BCM_CVRI @nationallipid #NLASessions #cardiotwitter https://t.co/DIsdL9yE1o - view on twitter
Mashup Score:1
HealioNLA issues new recommendations on lipid measurements in the management of CVD - 20 hours
Mashup Score:1
Accurate and precise laboratory lipid measurements are important. As such, the National Lipid Association has released a new scientific statement on lipid measurements in...
-
ICYMI: Peter W.F. Wilson, MD, FNLA, on how accurate, precise and detailed lipid reports that include desirable values and alert values are invaluable in guiding CV care @EmoryMedicine @VeteransHealth @nationallipid #NLASessions #cardiotwitter @LipidJournal https://t.co/J2CP4iDe7C - view on twitter
Much research is being conducted on novel therapeutics to reduce residual lipid-related risks, a speaker said at the National Lipid Association Scientific Sessions.“It has...
“It has never been a more exciting time to be in the field of lipids, in terms of what we can do for our patients now and, in particular, what’s coming down the pipeline,” @CBallantyneMD @BCMFromtheLabs @BCM_CVRI @nationallipid #NLASessions #cardiotwitter https://t.co/DIsdL9yE1o - view on twitter